NEW YORK, December 8, 2016 /PRNewswire/ --
The Healthcare Information Services industry provides services that offer health care providers secure access to clinical, administrative, and financial data that can be used to boost quality, improve safety, and increase efficiency across the sector. These services include software solutions, clinical content, hardware, and devices. Pre-market, Stock-Callers.com tracks the performances of the following equities: Premier Inc. (NASDAQ: PINC), WebMD Health Corp. (NASDAQ: WBMD), and Evolent Health Inc. (NYSE: EVH). Sign up today and download for free the research reports for the stocks covered today at:
On Wednesday, shares in Charlotte, North Carolina headquartered Premier Inc. recorded a trading volume of 468,463 shares. The stock ended at $30.13, declining 0.33% from the last trading session. The Company's shares have gained 5.68% in the last one month. The stock is trading below its 50-day moving average by 2.61%. Furthermore, shares of Premier, which together with its subsidiaries, operates as a healthcare improvement company in the US, have a Relative Strength Index (RSI) of 49.60.
On December 6th, 2016, Premier introduced an integrated solution allowing providers to track system-wide clinician performance across the care continuum. The Clinician Performance Management solution compares outcomes with peers and national benchmarks to forecast the potential financial impact of future reimbursements and prioritize areas of improvement. Building on Premier's hospital-focused physician performance metrics and its qualified clinical data registry, the Clinician Performance Management solution integrates both acute and ambulatory clinician performance data. PINC complete research report is just a click away at:
New York headquartered WebMD Health Corp.'s stock finished yesterday's session 0.41% lower at $53.32. A total volume of 950,096 shares was traded, which was above their three months average volume of 706,060 shares. The Company's shares have gained 5.02% in the last one month, 1.50% over the previous three months, and 10.39% on an YTD basis. The stock is trading above its 50-day moving average by 3.23%. Furthermore, shares of WebMD Health, which provides health information services to consumers, physicians and other healthcare professionals, employers, and health plans through its public and private online portals, mobile platforms, and health-focused publications in the US, have an RSI of 54.98.
On November 16th, 2016, WebMD Health announced that it has commenced a tender offer to purchase up to 2,000,000 shares of its common stock at a price of $55.00 per share. The number of shares proposed to be purchased in the tender offer represents approximately 5.1% of the approximately 39.2 million shares of WebMD's Common Stock outstanding as of November 10th, 2016. The tender offer will expire at 5:00 p.m., ET, on December 15th, 2016, unless extended by WebMD. On the terms and subject to the conditions of the tender offer, WebMD's stockholders will have the opportunity to tender some or all of their shares at a price of $55.00 per share. Stockholders whose shares are purchased in the tender offer will be paid $55.00 per share, net in cash, less any applicable withholding taxes and without interest, promptly after the expiration of the tender offer period. As of November 10th, 2016, WebMD had approximately $1.065 billion in cash and investments. WebMD will use a portion of its cash and investments to fund the tender offer. The complimentary report on WBMD can be downloaded at:
At the closing bell on Wednesday, shares in Virginia headquartered Evolent Health Inc. saw a decline of 2.01%, ending the day at $17.05. The stock recorded a trading volume of 275,015 shares. The Company's shares have advanced 40.79% since the start of this year. The stock is trading 5.54% below its 200-day moving average. Moreover, shares of Evolent Health, which through its subsidiary, Evolent Health LLC provides healthcare delivery and payment solutions in the US, have an RSI of 34.15.
In a SEC filing dated December 5th, 2016, Evolent Health (company) and Evolent Health LLC entered into a purchase agreement on November 29th, 2016, with J.P. Morgan Securities LLC and Goldman, Sachs & Co., to issue and sell $110.0 million aggregate principal amount of its 2.00% Convertible Senior Notes due 2021 in a private placement to qualified institutional buyers. The Company granted the Purchasers an option to purchase up to an additional $15.0 million aggregate principal amount of Notes, which Option was exercised on December 01st, 2016. The Notes were issued at an issue price of 100.00% of par for net proceeds of approximately $120.7 million, after deducting fees and estimated expenses. The closing of the Private Placement of the Notes occurred on December 5th, 2016. Upon receipt thereof, the Company loaned the net proceeds from the Private Placement to Evolent Health LLC. Evolent Health LLC intends to use such net proceeds for working capital and other general corporate purposes. Sign up for your complimentary report on EVH at:
Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
SC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email [email protected]. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Email: [email protected]
Phone number: +44 330 808 3765
Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Chelmsford Park SA